
---
title: '泽璟制药：启动盐酸杰克替尼片治疗中、重度特应性皮炎III期临床试验'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7716'
author: 证券时报网
comments: false
date: Wed, 01 Jun 2022 18:05:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7716'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688266" style="color: #2f67d1;text-decoration: none;" code="688266" target="_blank">泽璟制药</a>(688266)6月1日晚间公告，公司已于近日启动盐酸杰克替尼片治疗中、重度特应性皮炎III期临床试验。</p>

                  
</div>
            